Pyxis Oncology, Inc.
PYXSNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $115.18M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.03$5.55
- Volume (live)
- -
- Avg. volume (3M)
- 1.32M
Pyxis Oncology (PYXS) Stock Price & Financial Analysis
Pyxis Oncology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.66 - $1.79 |
|---|---|
| 52-Week High | $5.55 |
| 52-Week Low | $1.03 |
| Open | $1.79 |
| Volume (last close) | 908.23K |
| Average Volume (3M) | 1.32M |
| Revenue (TTM) | 11.04M |
|---|---|
| Net Income (TTM) | -88.73M |
| Free Cash Flow (TTM) | -67.92M |
| EPS (TTM) | −$1.41 |
| Profit Margin | -803.83% |
| Operating Margin | -834.44% |
| Return on Equity (ROE) | -775.59% |
| Debt to Equity | 1.56 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 115.18M |
|---|---|
| Shares Outstanding | 63.99M |
| Price to Sales (P/S) | 10.44 |
| Price to Book (P/B) | 10.07 |
| EV/EBITDA | -1.35 |
| 50-Day MA | $3.01 |
|---|---|
| 200-Day MA | $2.14 |
| 1-Year Change | −46.43% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Pyxis Oncology at a Glance
As of the Oct 16, 2026 close, Pyxis Oncology (PYXS) has a market capitalization of $115.18M. The stock trades at 10.4× sales. Over the trailing twelve months it lost $88.73M on revenue of $11.04M and burned $67.92M of free cash flow. Revenue grew 291.4% year over year.
As of its latest reported balance sheet, it holds $18.86M in cash and securities against $17.83M of debt, a net cash position of $1.02M.
Pyxis Oncology does not currently pay a dividend.
The share price is down 46.4% over the past year. At $1.68 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.03 to $5.55, below its 200-day moving average of $2.14.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $9.00, 435.7% above the Oct 16, 2026 close.
Frequently Asked Questions About Pyxis Oncology
What is the current stock price for PYXS?
As of the Oct 16, 2026 close, PYXS stock trades at $1.68. The 52-week range is $1.03–$5.55, with a day range of $1.66–$1.79.
What is the P/E ratio for PYXS?
The P/E ratio (Price-to-Earnings) for PYXS is shown in the Key Statistics section. This valuation metric helps compare Pyxis Oncology, Inc. to industry peers.
Does PYXS pay dividends?
Pyxis Oncology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PYXS?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for PYXS is Buy. The average 12-month price target is $9.00, a 435.7% upside from the Oct 16, 2026 close of $1.68.
What is the market cap of PYXS?
As of the Oct 16, 2026 close, Pyxis Oncology's market capitalization is $107.5M, classifying it as a micro-cap company. Pyxis Oncology operates in the Healthcare sector within the Biotechnology industry.